SCHEMBL8285307

SCHEMBL8285307

CC(=O)c1cccc(-c2cc3c(cn2)c(=O)cc(Nc2ccccc2)n3-c2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.42
APAF1 O14727 1/20 0.42
TDP2 O95551 1/20 0.42
ABL1 P00519 2/20 0.40
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
RIPK1 Q13546 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FYN P06241 3/20 0.39
KDM1A O60341 1/20 0.38
BRAF P15056 1/20 0.38
TP53 P04637 2/20 0.38
MAP4K4 O95819 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
AURKA O14965 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285278 0.88 MAPK1 (0.38) ABL1MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8286507 0.83 GSK3B (0.37) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL8286468 0.82 GSK3B (0.38) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL8287097 0.81 APAF1 (0.47) ATRAPAF1TDP2ABL1MAPT
SCHEMBL8286511 0.81 MAT2A (0.38) ATRMEN1KMT2AALDH1A1CLK4
SCHEMBL8287526 0.79 MAPK13 (0.38) ABL1MAPTKMT2ANPC1RAB9A
SCHEMBL8286496 0.79 FYN (0.37) NPC1ALDH1A1POLBFYNCDK8
SCHEMBL8287593 0.78 GSK3B (0.37) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL5872050 0.78 GAA (0.44) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8287205 0.77 GSK3B (0.37) JAK2CSF1RGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed